https://www.selleckchem.com/products/thz531.html
The short-term efficacy of paclitaxel-coated balloons (PCBs) has been established in femoropopliteal in-stent restenosis (ISR) lesions. The aim of this study was to compare 5-year clinical outcomes of patients with femoropopliteal ISR lesions undergoing percutaneous transluminal angioplasty (PTA) with and without PCB. After 11 propensity score matching, we extracted 50 patients with femoropopliteal ISR lesions undergoing PTA with (n= 25) and without (n= 25) IN.PACT PCB (Medtronic, Minneapolis, MN) from 106 consecutive ISR patients treate
Aimer
Commentaire
Partagez
